- £1.98bn
- £2.55bn
- £4.87bn
- 95
- 68
- 96
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,248 | 3,885 | 4,425 | 4,534 | 4,874 |
Cost of Revenue | |||||
Gross Profit | 320 | 383 | 468 | 494 | 496 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,146 | 3,706 | 4,208 | 4,317 | 4,602 |
Operating Profit | 103 | 179 | 216 | 217 | 272 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 80.7 | 153 | 192 | 197 | 247 |
Provision for Income Taxes | |||||
Net Income After Taxes | 50.6 | 134 | 304 | 155 | 202 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 50.4 | 134 | 304 | 155 | 202 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 50.4 | 134 | 304 | 155 | 202 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.074 | 0.095 | 0.25 | 0.132 | 0.13 |
Dividends per Share |